Delivery Order SPE2DR25D7055-SPE2DR26FV5ST
- Not listed
- The Defense Logistics Agency awarded a $17,232.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 22, 2025, with an ultimate completion date of December 23, 2025. This non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.42 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company will perform the work from its Corporate Office...
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,949.28 to AmerisourceBergen Drug Corp for Act-O-Vials on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,992.15 to AmerisourceBergen Drug Corp for Act-O-Vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order...
- The Defense Logistics Agency awarded a $2,656.66 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $28,884.34 to AmerisourceBergen Drug Corp for Act-O-Vials, with performance in Conshohocken, Pennsylvania. The contract, awarded on January 2, 2026, utilizes firm fixed pricing with an ultimate completion date of January 5, 2026. This delivery order was competitively awarded with no set-aside designation and operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.10 to AmerisourceBergen Drug Corp for Act-O-Vials on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the company's corporate office in Conshohocken, Pennsylvania, the same location that serves as the...
- SPE2DR25D7055Indefinite Delivery Contract
- SPE2DR25D7055-SPE2DR26FV5STDelivery Order
The Defense Logistics Agency awarded a $15,360.10 delivery order (Contract No. 4570419104) to AmerSourceBergen Drug Corp on January 7, 2026, for Act-O-Vials, with completion scheduled for January 8, 2026. This is a firm fixed-price, non-set-aside delivery order executed under AmerSourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This prime IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical supply requirements through competitive awards. This delivery order for Act-O-Vials represents a routine execution under the established master contract vehicle, enabling continued supply of essential medical products to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 1/6/26 |